Details for New Drug Application (NDA): 212278
✉ Email this page to a colleague
The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 212278
Tradename: | ATAZANAVIR SULFATE |
Applicant: | Hetero Labs Ltd Iii |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 212278
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 212278 | ANDA | Camber Pharmaceuticals, Inc. | 31722-653 | 31722-653-10 | 1000 CAPSULE in 1 BOTTLE (31722-653-10) |
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 212278 | ANDA | Camber Pharmaceuticals, Inc. | 31722-653 | 31722-653-31 | 100 BLISTER PACK in 1 CARTON (31722-653-31) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Feb 2, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Feb 2, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 300MG BASE | ||||
Approval Date: | Feb 2, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription